Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 47 Breast Neoplasms 34 Breast Neoplasms, Male 3 Neoplasms 2 Neoplasm Metastasis 2 Infertility 2 Advanced Breast Cancer 2 Sexual Dysfunction, Physiological 1 Recurrence 1 Prostate Adenocarcinoma 1 Primary Ovarian Insufficiency 1 Osteoporosis 1 Osteitis Deformans 1 Leiomyoma 1 Hot Flashes 1 Hemorrhage 1 Breast Cancer Invasive 1 Anemia 1 Advanced Prostate Cancer 1 Advanced Metastatic Breast Cancer 1

Interventions

relugolix 8 ulipristal acetate 7 telapristone acetate 7 estradiol, norethindrone drug combination 7 vilaprisan 6 asoprisnil 6 Estradiol 5 linzagolix 4 elagolix 4 Norethindrone Acetate 3 Leuprolide 3 Sugars 2 Progestins 2 epigallocatechin gallate 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Tea 1 Standard of Care 1 Sodium Chloride 1 Saline Solution 1 Misoprostol 1 Mifepristone 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Laparoscopy 1 Iron 1 Hysterectomy 1 Goserelin 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyoma × Goserelin × Clear all

NCT01581944 2012-04-20

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

Mt. Hope Maternity Hospital

Phase 3 Completed

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡